ICYMI: Patent Abuse Is Undermining American Health Care

The pharmaceutical company Allergan recently announced a decision to transfer the intellectual property rights of its eye treatment, Restasis, to the Saint Regis Mohawk Indian Tribe. While this novel decision has garnered a lot of attention, what has received far less attention is a flawed patent review process underlying the decision. Fortunately, Phil Goldberg, director of the Center for Civil Justice at the Progressive Policy Institute, is helping to explain how a well-intended law has led to